Males With Benign Prostatic Hyperplasia Symptoms Clinical Trial
Official title:
Impact of Beta 3 Agonist Mirabegron on Erectile Function on Patients With Benign Prostate Hyperplasia
Evaluation of impact of Mirabegron on erectile function for patients treated for BPH
50 patients (Group A) will receive Mirabegron & alpha blocker 50 patients (Group B) will receive alpha blocker only Evaluation using IIEF 5 scoring system ;